The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients: A report of three cases

Cancer

Volumn 78, Issue 10, 1996, Pages 2223-2228

  Wood, Brent Lee ^a,b   Sabath, Daniel ^a   Broudy, Virginia C ^a   Raghu, Ganesh ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Dept of Lab Medicine #357110 ^*  (United States)

Author keywords

lung; lymphoma; polymerase chain reaction; posttransplant lymphoproliferative disorders; transplant

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DNA DETERMINATION; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; HUMAN; IMMUNOPHENOTYPING; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0029973616     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19961115)78:10<2223::aid-cncr26>3.0.co;2-#     Document Type: Article

References (34)

1. Unilateral lung transplantation for pulmonary fibrosis. Toronto Lung Transplant Group. N Engl J Med 1986;314:1140-5.
2. Cooper JD, Patterson GA, Grossman R, Maurer J. Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis 1989; 139:303-7.
3. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, et al. Heart-lung transplantation:successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982;306:557-64.
4. Griffith BP, Hardesty RL, Armitage JM, Hattler BG, Pham SM, Keenan RJ, et al. A decade of lung transplantation. Ann Surg 1993;218:310-8.
5. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133:173-92.
6. Leblond V, Sutton L, Dorent R, Davi F, Bitker MO, Gabarre J, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 1995; 13:961-8.
7. Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995;86:3333-40.
8. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients:ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991;10:877-86.
9. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelford OH, Sninsky JJ, White TJ, editors. PCR protocols: A guide to methods and applications. San Diego: Academic Press Inc., 1990:153-8.
10. Korsmeyer SJ, Arnold A, Bakhshi A, Ravetch JV, Siebenlist U, Mieter PA, et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest 1983;71:301-13.
11. Dambaugh T, Beisel C, Hummel M, King W, Fennewald S, Cheung A, et al. Epstein-Barr virus (B95-8) DNA VII:molecular cloning and detailed mapping. Proc Natl Acad Sci USA 1980;77:2999-3003.
12. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992;1:246-55.
13. Goldberg YP, Andrew SE, Clarke LA, Hayden MR. A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. Hum Mol Genet 1993; 2:635-6.
14. Tait JF, Smith C, Xu L, Cookson BT. Structure and polymorphisms of the human annexin II (ANX3) gene. Genomics 1993; 18:79-86.
15. Chadburn A, Cesarman E, Liu YF, Addonizio L, Hsu D, Michler RE, et al. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. Cancer 1995; 75:2747-56.
16. Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol 1989; 2:583-92.
17. Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 1989;92:177-85.
18. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988;71:1234-43.
19. Penn I. Host origin of lymphomas in organ transplant recipients. Transplantation 1979;27:214.
20. Gen H, Breinig MC, Atchison RW, Ho M, McKnight JL. Epstein-Barr virus transmission via the donor organs in solid organ transplantation:polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol 1991;65:976-80.
21. Schutt G, Engemann R, Gassel HJ, Elfeldt R, Leimenstoll G, Westphal E, et al. Donor-transmitted non-Hodgkin's lymphoma after renal transplantation-a case report. Transplant Proc 1993;25:2131-2.
22. Gassel AM, Westphal E, Hansmann ML, Leimenstoll G, Gassel HJ. Malignant lymphoma of donor origin after renal transplantation: a case report. Hum Pathol 1991;22:1291-3.
23. Garnier JL, Berger F, Betuel H, Vuillaume M, Chapuis-Cellier C, Blanc N, et al. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation. Nephrol Dial Transplant 1989;4:818-23.
24. Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, et al. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 1990;49:944-53.
25. Maeda K, Hawkins ET, Oh HK, Kini SR, Van-Dyke DL. Malignant lymphoma in transplanted renal pelvis. Arch Pathol Lab Med 1986; 110:626-9.
26. Barkholt L, Billing H, Juliusson G, Porwit A, Ericzon BG, Groth CG. B-cell lymphoma in transplanted liver. Clinical, histological and radiological manifestations. Transpl Int 1991;4:8-11.
27. Hjelle B, Evans-Holm M, Yen TS, Garovoy M, Guis M, Edman JC. A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Transplantation 1989;47:945-8.
28. Randhawa PS, Yousem SA. Epstein-Barr virus-associated lymphoproliferative disease in a heart-lung allograft. Demonstration of host origin by restriction fragment-length polymorphism analysis. Transplantation 1990;49:126-30.
29. Meduri G, Fromentin L, Vieillefond A, Fries D. Donor-related non-Hodgkin's lymphoma in a renal allograft recipient. Transplant Proc 1991;23:2649.
30. Hegele RG, Bicknell SG, Bailey DJ, Cameron RG. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft. Arch Pathol Lab Med 1994;118:795-6.
31. Spiro IJ, Yandell DW, Li C, Saini S, Ferry J. Powelson J, et al. Brief report:lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med 1993;329:27-9.
32. Cherqui D, Duvoux C, Plassa F, Gaulard P, Julien M, Fagniez PL, et al. Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 1993;56:1023-6.
33. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol 1995; 103:748-55.
34. Smith ME, Bodmer WF, Bodmer JG. Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma [letter]. Lancet 1988;1 (8589):823-4.